BACKGROUND: C-reactive protein (CRP) is an acute phase protein produced in the liver. An elevated CRP is a nonspecific marker of inflammation. Additionally, it also appears to be a prognostic marker in several malignancies. Elevated CRP levels in adult patients with Hodgkin disease (HD) were reported previously. However, levels of CRP have not been evaluated in pediatric and adolescent HD patients. PROCEDURE: We analyzed CRP serum levels in 95 consecutive pediatric and adolescent patients with Hodgkin disease. CRP levels were correlated with stage, absence or presence of B symptoms, and prognosis. RESULTS: At the time of diagnosis increased serum CRP levels were found in 64 % (61/95) of the patients with a median of 21 mg/L (range: <5-211). Serum C-reactive protein levels correlated with stage and were higher in patients with B symptoms. Higher CRP levels were associated with an increased risk of relapse. CONCLUSION: In addition to soluble interleukin 2 receptor (sIL-2R) levels, CRP holds promise as a diagnostic and prognostic index and follow-up monitor in pediatric and adolescent patients with Hodgkin disease, and merits further investigation. Copyright 2003 Wiley-Liss, Inc.
BACKGROUND:C-reactive protein (CRP) is an acute phase protein produced in the liver. An elevated CRP is a nonspecific marker of inflammation. Additionally, it also appears to be a prognostic marker in several malignancies. Elevated CRP levels in adult patients with Hodgkin disease (HD) were reported previously. However, levels of CRP have not been evaluated in pediatric and adolescent HDpatients. PROCEDURE: We analyzed CRP serum levels in 95 consecutive pediatric and adolescent patients with Hodgkin disease. CRP levels were correlated with stage, absence or presence of B symptoms, and prognosis. RESULTS: At the time of diagnosis increased serum CRP levels were found in 64 % (61/95) of the patients with a median of 21 mg/L (range: <5-211). Serum C-reactive protein levels correlated with stage and were higher in patients with B symptoms. Higher CRP levels were associated with an increased risk of relapse. CONCLUSION: In addition to soluble interleukin 2 receptor (sIL-2R) levels, CRP holds promise as a diagnostic and prognostic index and follow-up monitor in pediatric and adolescent patients with Hodgkin disease, and merits further investigation. Copyright 2003 Wiley-Liss, Inc.
Authors: Mara M Epstein; Ellen T Chang; Yawei Zhang; Teresa T Fung; Julie L Batista; Richard F Ambinder; Tongzhang Zheng; Nancy E Mueller; Brenda M Birmann Journal: Am J Epidemiol Date: 2015-07-15 Impact factor: 4.897
Authors: Shenying Fang; Yuling Wang; Dawen Sui; Huey Liu; Merrick I Ross; Jeffrey E Gershenwald; Janice N Cormier; Richard E Royal; Anthony Lucci; Christopher W Schacherer; Julie M Gardner; John D Reveille; Roland L Bassett; Li-E Wang; Qingyi Wei; Christopher I Amos; Jeffrey E Lee Journal: J Clin Oncol Date: 2015-03-16 Impact factor: 44.544
Authors: Murat Bolayirli; Hande Turna; Timur Orhanoğlu; Resat Ozaras; Mahmut Ilhan; Mustafa Ozgüroğlu Journal: Med Oncol Date: 2007 Impact factor: 3.064
Authors: Talita Máira Bueno da Silveira da Rocha; Ana Luiza Pereira Miranda Silva; Sérgio Costa Fortier; Carlos Sérgio Chiattone Journal: Rev Bras Hematol Hemoter Date: 2015-06-03